Search results for "very"

showing 10 items of 6927 documents

Analysis of the Transcriptome of the Red Seaweed Grateloupia imbricata with Emphasis on Reproductive Potential

2018

Grateloupia imbricata is an intertidal marine seaweed and candidate model organism for both industry and academic research, owing to its ability to produce raw materials such as carrageenan. Here we report on the transcriptome of G. imbricata with the aim of providing new insights into the metabolic pathways and other functional pathways related to the reproduction of Grateloupia species. Next-generation sequencing was carried out with subsequent de novo assembly and annotation using state-of-the-art bioinformatic protocols. The results show the presence of transcripts required for the uptake of glycerol, which is a specific carbon source for in vitro culture of G. imbricata and nucleotide …

0301 basic medicineved/biology.organism_classification_rank.speciescarbon sourcesPharmaceutical ScienceRed algaetranscriptome shotgun assemblyreproductionTranscriptome03 medical and health scienceschemistry.chemical_compoundBiosynthesisgrowth regulatorsDrug DiscoveryModel organismlcsh:QH301-705.5Pharmacology Toxicology and Pharmaceutics (miscellaneous)red algaeMethyl jasmonatebiologyved/biologybiology.organism_classificationSporeMetabolic pathway030104 developmental biologylcsh:Biology (General)chemistryBiochemistryPolyamineMarine Drugs
researchProduct

Synthesis and cytotoxic activity of new artemisinin hybrid molecules against human leukemia cells

2017

A series of new artemisinin-derived hybrids which incorporate cholic acid moieties have been synthesized and evaluated for their antileukemic activity against sensitive CCRF-CEM and multidrug-resistant CEM/ADR5000 cells. The new hybrids 20-28 showed IC50 values in the range of 0.019µM-0.192µM against CCRF-CEM cells and between 0.345µM and 7.159µM against CEM/ADR5000 cells. Amide hybrid 25 proved the most active compound against both CCRF-CEM and CEM/ADR5000 cells with IC50 value of 0.019±0.001µM and 0.345±0.031µM, respectively. A relatively low cross resistance to hybrids 20-28 in the range of 5.7-fold to 46.1-fold was measured. CEM/ADR5000 cells showed higher resistance than CCRF-CEM to al…

0301 basic medicinevirusesClinical BiochemistryPharmaceutical ScienceAntineoplastic AgentsBiochemistryAntileukemic agentStructure-Activity Relationship03 medical and health scienceschemistry.chemical_compound0302 clinical medicineimmune system diseaseshemic and lymphatic diseasesAmideDrug DiscoveryTumor Cells CulturedmedicineHumansCytotoxic T cellDoxorubicinArtemisininMolecular BiologyIC50Cross-resistanceCell ProliferationLeukemiaDose-Response Relationship DrugMolecular StructureOrganic ChemistryCholic acidhemic and immune systemsArtemisinins030104 developmental biologyBiochemistrychemistry030220 oncology & carcinogenesisMolecular MedicineDrug Screening Assays Antitumormedicine.drugBioorganic & Medicinal Chemistry
researchProduct

A Bimolecular Multicellular Complementation System for the Detection of Syncytium Formation: A New Methodology for the Identification of Nipah Virus …

2019

Fusion of viral and cellular membranes is a key step during the viral life cycle. Enveloped viruses trigger this process by means of specialized viral proteins expressed on their surface, the so-called viral fusion proteins. There are multiple assays to analyze the viral entry including those that focus on the cell-cell fusion induced by some viral proteins. These methods often rely on the identification of multinucleated cells (syncytium) as a result of cell membrane fusions. In this manuscript, we describe a novel methodology for the study of cell-cell fusion. Our approach, named Bimolecular Multicellular Complementation (BiMuC), provides an adjustable platform to qualitatively and quanti…

0301 basic medicinevirusesmembrane fusionlcsh:QR1-502virusNipah virusBiologyGiant Cells01 natural scienceslcsh:MicrobiologySmall Molecule Libraries03 medical and health sciencesVirus entryViral envelopeViral life cycleViral entryVirologyDrug DiscoveryHumansSyncytiumDrug discoveryBrief ReportbiomolèculesHigh-throughput screeningLipid bilayer fusionVirus InternalizationFusion proteinHigh-Throughput Screening Assays0104 chemical sciencesCell biologyBimolecular complementation010404 medicinal & biomolecular chemistryMulticellular organismHEK293 Cells030104 developmental biologyInfectious DiseasesViruses
researchProduct

Elements of biomechanics correlated to the body mass index in knee osteoarthritis

2020

Introduction. Osteoarthritis is considered a complex biopsychosocial condition, with consequences for the patient, the family, society and public health. Age is considered the main risk factor in the occurrence of osteoarthritis. Studies show that 2 out of 3 obese individuals associate knee osteoarthritis whereas the incidence of the latter increases at the same time with increasing body mass index. Obesity contributes to the initiation of the process of osteoarthritis by the mechanical overload of the joint, causing cartilage damage with increasing horizontal cracks and the increased incidence of the osteophites in the knee. Purpose. We conducted a study in patients with knee osteoarthriti…

030203 arthritis & rheumatologyOrthodontics0303 health sciencesobesityknee biomechanicsbusiness.industrylcsh:RM1-950BiomechanicsGeneral MedicineOsteoarthritismedicine.disease03 medical and health sciencesosteoarthritisrecovery0302 clinical medicinelcsh:Therapeutics. PharmacologymedicinebusinessBody mass index030304 developmental biologyBalneo Research Journal
researchProduct

The quality of life - an indicator for assessing the recovery program in patients diagnosed with degenerative disorders

2020

Introduction. Osteoarthritis is a chronic joint disease, a progressive non-inflammatory arthropathy-type. Globally, around 1.7 billion people are affected by musculoskeletal and rheumatic diseases, which indicates an increase in the last 20 years of around 45%. Material and method. The objectives of the treatment of patients diagnosed with osteoarthritis were: decreasing the pain, increasing joint mobility, muscle strength, trophic and muscle tone, increasing the quality of life and reintegration into the social and family environment. Demographic data and the functional status were assessed using the VAS scale, the WOMAC scale, the QOL scale. Results and discussions. The pain, the most imp…

030203 arthritis & rheumatologyPediatricsmedicine.medical_specialtykinetotherapyDegenerative Disorderbusiness.industrylcsh:RM1-950General Medicine010402 general chemistry01 natural sciences0104 chemical sciences03 medical and health sciencesosteoarthritisthe complex recovery treatment0302 clinical medicinelcsh:Therapeutics. PharmacologyMedicineIn patientbusinessthe quality of lifeBalneo Research Journal
researchProduct

Giant cell arteritis (Horton's disease) in very elderly patients aged 80 years and older: A study of 25 cases

2015

Aim Analysis of the characteristics of very elderly patients with giant cell arteritis (GCA). Methods Patients aged 80 years and older diagnosed with GCA in our department between 1 January 2002 and 31 July 2008 were retrospectively included. For each patient, we recorded general characteristics, reason(s) for hospitalization, specialty of the physician or department that referred the patient to us, medical history, treatment at admission, GCA clinical features, time to diagnosis of GCA, biological screening and GCA treatment. Results We analyzed 25 clinical records, 18 women and seven men with a mean age of 83.9 years. General weakness, visual loss and inflammatory syndrome were the princi…

030203 arthritis & rheumatologyWeaknessPediatricsmedicine.medical_specialtyeducation.field_of_studymedicine.diagnostic_testbusiness.industryPopulationSpecialtyDiseasemedicine.diseaseSurgeryVery frequent030207 dermatology & venereal diseases03 medical and health sciencesGiant cell arteritis0302 clinical medicineBiopsymedicineMedical historymedicine.symptombusinesseducationGeriatrics & Gerontology International
researchProduct

2021

The biological activities of shancigusin C (1) and bletistrin G (2), natural products isolated from orchids, are reported along with their first total syntheses. The total synthesis of shancigusin C (1) was conducted by employing the Perkin reaction to forge the central stilbene core, whereas the synthesis of bletistrin G (2) was achieved by the Wittig olefination followed by several regioselective aromatic substitution reactions. Both syntheses were completed by applying only renewable starting materials according to the principles of xylochemistry. The cytotoxic properties of shancigusin C (1) and bletistrin G (2) against tumor cells suggest suitability as a starting point for further str…

0303 health sciences010405 organic chemistryStereochemistryChemistryOrganic ChemistryPharmaceutical ScienceRegioselectivityTotal synthesisTumor cellsElectrophilic aromatic substitution01 natural sciences0104 chemical sciencesAnalytical Chemistry03 medical and health sciencesChemistry (miscellaneous)Perkin reactionDrug DiscoveryWittig reactionMolecular MedicinePhysical and Theoretical Chemistry030304 developmental biologyBiological evaluationMolecules
researchProduct

Topographical geometric factors governing the biological activities of methomyl derivatives on binding receptors of maize mitochondria

1986

Abstract The topographical study of the binding receptors of T and N mitochondria was undertaken with methomyl derivatives acting as molecular probes. The two biological activities related to topography and geometric isomerism are distinguishable from the receptor sites of T and N mitochondria.

0303 health sciences010405 organic chemistry[SDV]Life Sciences [q-bio]030302 biochemistry & molecular biologyOrganic ChemistryMethomylMitochondrion01 natural sciencesBiochemistry0104 chemical sciences[SDV] Life Sciences [q-bio]03 medical and health scienceschemistry.chemical_compoundchemistryBiochemistryDrug DiscoveryReceptorMolecular probeMolecular BiologyCis–trans isomerismComputingMilieux_MISCELLANEOUS
researchProduct

2020

The term “amyloid” refers to proteinaceous deposits of peptides that might be generated from larger precursor proteins e.g., by proteolysis. Common to these peptides is a stable cross-β dominated secondary structure which allows self-assembly, leading to insoluble oligomers and lastly to fibrils. These highly ordered protein aggregates have been, for a long time, mainly associated with human neurodegenerative diseases such as Alzheimer’s disease (Amyloid-β peptides). However, they also exert physiological functions such as in release of deposited hormones in human beings. In the light of the rediscovery of our microbial commensals as important companions in health and disease, the fact that…

0303 health sciencesAmyloidmedicine.diagnostic_testMicroorganismAmyloidosisProteolysisOrganic ChemistryNeurodegenerationPharmaceutical ScienceBiologyProtein aggregationmedicine.diseaseAnalytical Chemistry03 medical and health sciences0302 clinical medicineBiochemistryChemistry (miscellaneous)Drug DiscoverymedicineMolecular MedicinePhysical and Theoretical Chemistry030217 neurology & neurosurgery030304 developmental biologyMolecules
researchProduct

Positron Emission Tomography Imaging of Neurotensin Receptor-Positive Tumors with 68 Ga-Labeled Antagonists: The Chelate Makes the Difference Again

2021

Neurotensin receptor 1 (NTS1) is involved in the development and progression of numerous cancers, which makes it an interesting target for the development of diagnostic and therapeutic agents. A small molecule NTS1 antagonist, named [177Lu]Lu-IPN01087, is currently evaluated in phase I/II clinical trials for the targeted therapy of neurotensin receptor-positive cancers. In this study, we synthesized seven compounds based on the structure of NTS1 antagonists, bearing different chelating agents, and radiolabeled them with gallium-68 for PET imaging. These compounds were evaluated in vitro and in vivo in mice bearing a HT-29 xenograft. The compound [68Ga]Ga-bisNODAGA-16 showed a promising biod…

0303 health sciencesBiodistributionNeurotensin receptor 1medicine.diagnostic_testChemistrymedicine.disease3. Good health03 medical and health scienceschemistry.chemical_compound0302 clinical medicinePositron emission tomographyIn vivo030220 oncology & carcinogenesisDrug DiscoverymedicineCancer research[INFO.INFO-IM]Computer Science [cs]/Medical ImagingMolecular MedicineAdenocarcinoma[CHIM]Chemical SciencesNeurotensin receptorReceptorComputingMilieux_MISCELLANEOUS030304 developmental biologyNeurotensin
researchProduct